Cargando…
Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia
BACKGROUND: Catheter ablation of slow-pathway (CaSP) has been reported to be effective in patients with dual atrioventricular nodal conduction properties (dcp-AVN) and clinical ECG documentation but without the induction of tachycardia during electrophysiological studies (EPS). However, it is unknow...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870342/ https://www.ncbi.nlm.nih.gov/pubmed/29580297 http://dx.doi.org/10.1186/s40001-018-0314-0 |
_version_ | 1783309460597374976 |
---|---|
author | Gerguri, Shqipe Jathanna, Nikesh Lin, Tina Müller, Patrick Clasen, Lukas Schmidt, Jan Kurt, Muhammed Shin, Dong-In Blockhaus, Christian Kelm, Malte Fürnkranz, Alexander Makimoto, Hisaki |
author_facet | Gerguri, Shqipe Jathanna, Nikesh Lin, Tina Müller, Patrick Clasen, Lukas Schmidt, Jan Kurt, Muhammed Shin, Dong-In Blockhaus, Christian Kelm, Malte Fürnkranz, Alexander Makimoto, Hisaki |
author_sort | Gerguri, Shqipe |
collection | PubMed |
description | BACKGROUND: Catheter ablation of slow-pathway (CaSP) has been reported to be effective in patients with dual atrioventricular nodal conduction properties (dcp-AVN) and clinical ECG documentation but without the induction of tachycardia during electrophysiological studies (EPS). However, it is unknown whether CaSP is beneficial in the absence of pre-procedural ECG documentation and without the induction of tachycardia during EPS. The aim of this study was to evaluate long-term results after a “pure” empirical CaSP (peCaSP). METHODS: 334 consecutive patients who underwent CaSP (91 male, 47.5 ± 17.6 years) were included in this study. Sixty-three patients (19%) who had no pre-procedural ECG documentation, and demonstrated dcp-AVN with a maximum of one echo-beat were assigned to the peCaSP group. The remaining 271 patients (81%) were assigned to the standard CaSP group (stCaSP). Clinical outcomes of the two groups were compared, based on ECG documented recurrence or absence of tachycardia and patients’ recorded symptoms. RESULTS: CaSP was performed in all patients without any major complications including atrioventricular block. During follow-up (909 ± 435 days), 258 patients (77%) reported complete cessation of clinical symptoms. There was no statistically significant difference in the incidence of AVNRT recurrence between the peCaSP and stCaSP groups (1/63 [1.6%] vs 3/271 [1.1%], P = 0.75). Complete cessation of clinical symptoms was noted significantly less frequently in patients after peCaSP (39/63 [62%] vs 219/271 [81%], P = 0.0013). The incidence of non-AVNRT atrial tachyarrhythmias (AT) was significantly higher in patients after peCaSP (5/63 [7.9%] vs 1/271 [0.4%], P = 0.0011). CONCLUSION: A higher incidence of other AT and subjective symptom persistence are demonstrated after peCaSP, while peCaSP improves clinical symptoms in 60% of patients with non-documented on–off tachycardia. |
format | Online Article Text |
id | pubmed-5870342 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58703422018-03-29 Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia Gerguri, Shqipe Jathanna, Nikesh Lin, Tina Müller, Patrick Clasen, Lukas Schmidt, Jan Kurt, Muhammed Shin, Dong-In Blockhaus, Christian Kelm, Malte Fürnkranz, Alexander Makimoto, Hisaki Eur J Med Res Research BACKGROUND: Catheter ablation of slow-pathway (CaSP) has been reported to be effective in patients with dual atrioventricular nodal conduction properties (dcp-AVN) and clinical ECG documentation but without the induction of tachycardia during electrophysiological studies (EPS). However, it is unknown whether CaSP is beneficial in the absence of pre-procedural ECG documentation and without the induction of tachycardia during EPS. The aim of this study was to evaluate long-term results after a “pure” empirical CaSP (peCaSP). METHODS: 334 consecutive patients who underwent CaSP (91 male, 47.5 ± 17.6 years) were included in this study. Sixty-three patients (19%) who had no pre-procedural ECG documentation, and demonstrated dcp-AVN with a maximum of one echo-beat were assigned to the peCaSP group. The remaining 271 patients (81%) were assigned to the standard CaSP group (stCaSP). Clinical outcomes of the two groups were compared, based on ECG documented recurrence or absence of tachycardia and patients’ recorded symptoms. RESULTS: CaSP was performed in all patients without any major complications including atrioventricular block. During follow-up (909 ± 435 days), 258 patients (77%) reported complete cessation of clinical symptoms. There was no statistically significant difference in the incidence of AVNRT recurrence between the peCaSP and stCaSP groups (1/63 [1.6%] vs 3/271 [1.1%], P = 0.75). Complete cessation of clinical symptoms was noted significantly less frequently in patients after peCaSP (39/63 [62%] vs 219/271 [81%], P = 0.0013). The incidence of non-AVNRT atrial tachyarrhythmias (AT) was significantly higher in patients after peCaSP (5/63 [7.9%] vs 1/271 [0.4%], P = 0.0011). CONCLUSION: A higher incidence of other AT and subjective symptom persistence are demonstrated after peCaSP, while peCaSP improves clinical symptoms in 60% of patients with non-documented on–off tachycardia. BioMed Central 2018-03-27 /pmc/articles/PMC5870342/ /pubmed/29580297 http://dx.doi.org/10.1186/s40001-018-0314-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Gerguri, Shqipe Jathanna, Nikesh Lin, Tina Müller, Patrick Clasen, Lukas Schmidt, Jan Kurt, Muhammed Shin, Dong-In Blockhaus, Christian Kelm, Malte Fürnkranz, Alexander Makimoto, Hisaki Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia |
title | Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia |
title_full | Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia |
title_fullStr | Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia |
title_full_unstemmed | Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia |
title_short | Clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on–off tachycardia |
title_sort | clinical impact of “pure” empirical catheter ablation of slow-pathway in patients with non-ecg documented clinical on–off tachycardia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870342/ https://www.ncbi.nlm.nih.gov/pubmed/29580297 http://dx.doi.org/10.1186/s40001-018-0314-0 |
work_keys_str_mv | AT gergurishqipe clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia AT jathannanikesh clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia AT lintina clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia AT mullerpatrick clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia AT clasenlukas clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia AT schmidtjan clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia AT kurtmuhammed clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia AT shindongin clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia AT blockhauschristian clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia AT kelmmalte clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia AT furnkranzalexander clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia AT makimotohisaki clinicalimpactofpureempiricalcatheterablationofslowpathwayinpatientswithnonecgdocumentedclinicalonofftachycardia |